ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart
about
Role of Cytosolic Calcium Diffusion in Murine Cardiac Purkinje CellsThe Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo ExperimentsOptical Read-out of Neural Activity in Mammalian Peripheral Axons: Calcium Signaling at Nodes of Ranvier.Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmiasInter-subject variability in human atrial action potential in sinus rhythm versus chronic atrial fibrillation.Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse.In Vivo and In Silico Investigation Into Mechanisms of Frequency Dependence of Repolarization Alternans in Human Ventricular CardiomyocytesORM-10103: a significant advance in sodium-calcium exchanger pharmacology?Bioelectric impact of pathological angiogenesis on vascular function.Targeting calcium signaling in cancer therapy.Novel experimental results in human cardiac electrophysiology: measurement of the Purkinje fibre action potential from the undiseased human heart.Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.Dyssynchronous calcium removal in heart failure-induced atrial remodeling.The investigation of the cellular electrophysiological and antiarrhythmic effects of a novel selective sodium-calcium exchanger inhibitor, GYKB-6635, in canine and guinea-pig hearts.Chronic pharmacological blockade of the Na+ /Ca2+ exchanger modulates the growth and development of the Purkinje cell dendritic arbor in mouse cerebellar slice cultures.Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity
P2860
Q26740389-967B212E-A561-4D53-871E-64880AFB87E3Q28553447-B7078304-EFD1-4454-ABA2-AD3A1D1CD9B0Q33916224-CE6CCFEB-CE86-44C4-8AC9-903223952780Q34914184-6701503F-2928-422D-A794-5547928437B4Q35231876-03F21309-3BB7-4710-8B9F-988F46ED1209Q36333205-D98AD03F-EB92-44AA-9155-D8494FDFF78AQ36481211-CBCC9D3F-D0CD-43F5-BD9D-B001EF57AF72Q37237155-AA1C4DBA-1ADF-47D7-8D2A-C22E2368DDEAQ37258464-22CA5B10-A6E1-4AD5-B601-DB0A370D9292Q39101957-596DA5EA-42CE-4684-8EE3-9CECF7091453Q40592624-D472794A-8807-4D9C-B2A7-E95AE54F6084Q41952606-8B3B84C8-3D57-4F0A-881D-7B80C60D099FQ46369408-96978544-4BB5-404E-8206-7A24C0355A44Q46476410-8730C90E-0551-4EFE-8E69-C2D7068C3D4AQ48115443-4891E92C-AAF7-4E8D-A2CF-94A9E1CFF4D1Q58693859-CEF4328A-DA81-452B-80DD-B6EE6B9F7849
P2860
ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ORM-10103, a novel specific in ...... arizations in the canine heart
@en
ORM-10103, a novel specific in ...... rizations in the canine heart.
@nl
type
label
ORM-10103, a novel specific in ...... arizations in the canine heart
@en
ORM-10103, a novel specific in ...... rizations in the canine heart.
@nl
prefLabel
ORM-10103, a novel specific in ...... arizations in the canine heart
@en
ORM-10103, a novel specific in ...... rizations in the canine heart.
@nl
P2093
P2860
P356
P1476
ORM-10103, a novel specific in ...... arizations in the canine heart
@en
P2093
J Levijoki
P2860
P304
P356
10.1111/BPH.12228
P407
P577
2013-10-01T00:00:00Z